Burning Rock Biotech Ltd. ADR (BNR): Price and Financial Metrics


Burning Rock Biotech Ltd. ADR (BNR): $2.66

-0.25 (-8.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BNR Stock Price Chart Interactive Chart >

Price chart for BNR

BNR Price/Volume Stats

Current price $2.66 52-week high $29.16
Prev. close $2.91 52-week low $1.74
Day low $2.45 Volume 1,107,400
Day high $2.98 Avg. volume 510,494
50-day MA $3.32 Dividend yield N/A
200-day MA $9.53 Market Cap 279.59M

Burning Rock Biotech Ltd. ADR (BNR) Company Bio


Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The company operates through following segment: central laboratory business, in-hospital business and pharma research and development services. Its products and clinical applications including companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. Burning Rock Biotech was founded by Yu Sheng Han in 2014 and is headquartered in Guangzhou, China.


BNR Latest News Stream


Event/Time News Detail
Loading, please wait...

BNR Latest Social Stream


Loading social stream, please wait...

View Full BNR Social Stream

Latest BNR News From Around the Web

Below are the latest news stories about Burning Rock Biotech Ltd that investors may wish to consider to help them evaluate BNR as an investment opportunity.

Yacktman Fund Buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Associated British ...

Investment company Yacktman Fund (Current Portfolio) buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Associated British Foods PLC, Samsung Electronics Co, Hyundai Motor Co, sells Brenntag SE, Macy's Inc, The Walt Disney Co, Stanley Electric Co during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Yacktman Fund.

Yahoo | January 17, 2022

Yacktman Focused Fund Buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Hyundai ...

Investment company Yacktman Focused Fund (Current Portfolio) buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Hyundai Motor Co, Yuasa Trading Co, Hyundai Motor Co, sells Brenntag SE, The Walt Disney Co, Macy's Inc, First Hawaiian Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Yacktman Focused Fund.

Yahoo | January 17, 2022

Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 Million

GUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the Company expects its 2021 revenue to be at or slightly above RMB500 million. The Company is pleased with the recent progress achieved, despite elevated COVID impact that has been ongoing since the beginning of November, including the first diagnosed Omicron case in China and increased lock-downs in December.

Yahoo | December 29, 2021

Burning Rock Announces Results of 2021 Annual General Meeting

GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2021 annual general meeting held today were duly passed. Specifically, the shareholders passed the following resolutions approving: the ratification of the appointment of Ernst

Yahoo | December 28, 2021

Analysts Anticipate Burning Rock Biotech Limited (NASDAQ:BNR) Will Post Earnings of $0.12 Per Share

Brokerages forecast that Burning Rock Biotech Limited (NASDAQ:BNR) will announce earnings per share (EPS) of $0.12 for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Burning Rock Biotechs earnings. Burning Rock Biotech posted earnings of ($0.23) per share in the same quarter last year, which suggests a positive year-over-year growth []

Transcript Daily | December 19, 2021

Read More 'BNR' Stories Here

BNR Price Returns

1-mo 11.76%
3-mo -74.17%
6-mo -74.00%
1-year -90.44%
3-year N/A
5-year N/A
YTD -72.09%
2021 -58.74%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5337 seconds.